🇺🇸 UTHR — United Therapeutics Corporation
Salud CompraPrecio actual
601,32 USD
Máx. histórico
601,32
0 días
Split 2:1 del 23/09/2009
Caída desde máximo
En máximo
Rango 52 semanas
430,02 – 609,99
Variación hoy
+0,87%
Cierre anterior
596,13
Rango de hoy
596,14 – 606,16
Volumen hoy
595.233
Peor caída histórica
-93,18%
12/07/2000 → 10/12/2001
Recuperado en 3311 días
Volatilidad anualizada ⓘ
46,95%
- Nombre completo
- United Therapeutics Corporation
- Divisa
- USD
- Mercado
- NasdaqGS
- Sector
- Salud
- Industria
- Drug Manufacturers - Specialty & Generic
- Empleados
- 1.400
- PER ⓘ
- 21,54 (puede no estar actualizado)
- Dividend yield
- 0,00% (puede no estar actualizado)
- Precio objetivo analistas
- 670,93 USD (puede no estar actualizado)
- Primera cotización
- 17/06/1999
- Precio actualizado
- hace 19 horas
United Therapeutics Corporation engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. It offers Tyvaso DPI, an inhaled dry powder via pre-filled and single-use cartridges; Nebulized Tyvaso, an inhaled solution via ultrasonic nebulizer; Remodulin (treprostinil) injection to treat patients with pulmonary arterial hypertension to diminish symptoms associated with exercise; Orenitram, a tablet dosage form of treprostinil, to delay disease progression and improve exercise capacity in PAH patients; and Adcirca, an oral PDE-5 inhibitor to enhance the exercise ability in PAH patients. It also markets and sells Unituxin (dinutuximab) injection, a monoclonal antibody for high-risk neuroblastoma; and Remunity Pump, which contains a pump and separate controller for Remodulin. In addition, it is involved in developing RemunityPRO Pump and Ralinepag for the treatment of PAH;and Nebulized Tyvaso, for the treatment of idiopathic pulmonary fibrosis, as well as xenografts, which are development-stage organ products. Further, it provides preclinical products, including EVLP/CLES, for lung transplant; UKidney, UHeart, UThymoKidney, a development-stage gene-edited porcine kidneys and hearts for xenotransplantation; ULobe, for allogeneic regenerative medicine; ULung, for autologous regenerative medicine; IVIVA Kidney, for autologous regenerative medicine; miroliver, for allogeneic regenerative medicine; and mirokidney, for allogeneic regenerative medicine. It has licensing and collaboration agreements with DEKA Research & Development Corp. to develop a semi-disposable system for the subcutaneous delivery of treprostinil; MannKind Corporation to develop and license treprostinil inhalation powder and the Dreamboat device; and Arena Pharmaceuticals, Inc. to develop Ralinepag. The company was founded in 1996 and is headquartered in Silver Spring, Maryland.
| Fecha | Ratio |
|---|---|
| 23/09/2009 | 2:1 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 17/01/2025 | 372,34 | 372,34 | 357,25 | 358,93 | -2,04% | 4,05% | 248.300 |
| 16/01/2025 | 362,74 | 369,71 | 362,74 | 366,39 | +1,31% | 1,92% | 255.000 |
| 15/01/2025 | 369,52 | 370,48 | 360,36 | 361,64 | -0,84% | 2,74% | 303.100 |
| 14/01/2025 | 361,97 | 366,48 | 357,55 | 364,70 | +0,50% | 2,47% | 295.000 |
| 13/01/2025 | 366,64 | 368,36 | 361,06 | 362,88 | -0,57% | 1,99% | 277.000 |
| 10/01/2025 | 362,94 | 365,33 | 358,80 | 364,97 | -0,45% | 1,80% | 264.900 |
| 08/01/2025 | 363,99 | 367,41 | 360,00 | 366,61 | +1,18% | 2,04% | 252.800 |
| 07/01/2025 | 355,94 | 362,98 | 355,81 | 362,33 | +1,95% | 2,01% | 190.700 |
| 06/01/2025 | 355,70 | 358,67 | 351,05 | 355,39 | -0,26% | 2,14% | 268.100 |
| 03/01/2025 | 360,92 | 364,19 | 355,87 | 356,33 | -1,08% | 2,31% | 235.100 |
| 02/01/2025 | 352,33 | 360,97 | 350,93 | 360,22 | +2,09% | 2,85% | 287.500 |
| 31/12/2024 | 359,34 | 360,30 | 352,24 | 352,84 | -1,34% | 2,24% | 266.900 |
| 30/12/2024 | 358,00 | 361,44 | 352,56 | 357,64 | -0,64% | 2,48% | 268.400 |
| 27/12/2024 | 362,22 | 364,60 | 357,31 | 359,96 | -1,14% | 2,01% | 133.600 |
| 26/12/2024 | 360,70 | 365,02 | 360,20 | 364,10 | +0,90% | 1,34% | 220.800 |
| 24/12/2024 | 363,46 | 364,48 | 360,87 | 360,87 | -0,76% | 0,99% | 138.400 |
| 23/12/2024 | 359,59 | 364,95 | 356,00 | 363,65 | +1,13% | 2,49% | 238.000 |
| 20/12/2024 | 359,50 | 363,90 | 357,99 | 359,58 | -0,16% | 1,64% | 1.009.200 |
| 19/12/2024 | 357,55 | 364,61 | 350,60 | 360,16 | +0,73% | 3,92% | 335.200 |
| 18/12/2024 | 379,59 | 383,00 | 356,06 | 357,55 | -5,83% | 7,10% | 538.000 |
| 17/12/2024 | 372,19 | 381,50 | 372,19 | 379,69 | +1,84% | 2,50% | 347.000 |
| 16/12/2024 | 362,35 | 373,17 | 362,00 | 372,83 | +3,05% | 3,08% | 336.000 |
| 13/12/2024 | 362,40 | 362,94 | 358,82 | 361,81 | +0,06% | 1,14% | 293.200 |
| 12/12/2024 | 362,00 | 364,91 | 360,46 | 361,61 | -0,15% | 1,23% | 244.800 |
| 11/12/2024 | 363,51 | 366,07 | 360,59 | 362,16 | -0,02% | 1,51% | 212.800 |
| 10/12/2024 | 368,02 | 368,02 | 358,55 | 362,24 | -1,30% | 2,57% | 262.200 |
| 09/12/2024 | 370,69 | 371,93 | 362,44 | 367,00 | -0,72% | 2,56% | 246.500 |
| 06/12/2024 | 373,58 | 378,27 | 367,13 | 369,67 | -1,26% | 2,98% | 199.300 |
| 05/12/2024 | 372,17 | 377,00 | 369,07 | 374,37 | -0,01% | 2,13% | 241.700 |
| 04/12/2024 | 368,98 | 374,92 | 367,94 | 374,40 | +1,52% | 1,89% | 151.200 |